Waystar Stock: Quiet Pullback, Big Questions After Healthcare IT Rally
Waystar (NASDAQ: WAY) shares have experienced a quiet pullback after an initial post-IPO rally, raising questions among investors despite strong underlying fundamentals in US healthcare IT. The company, which provides healthcare payments and revenue-cycle software, is positioned in a growing market where hospitals and physician groups need automation to optimize payments amid rising denials and labor costs. The article explores the reasons for the stock's recent softness, including software rotation, profit-taking, and investor reactions to broader healthcare commentary, while noting Wall Street analysts generally maintain a positive long-term outlook.
Waystar AI Delivers Industry-Leading Outcomes, Earns #1 Client Ranking
Waystar (Nasdaq: WAY) has been ranked number one in client satisfaction for its AI capabilities in revenue cycle management, according to a Black Book Market Research™ survey. The company excelled in client-reported outcomes, execution, and satisfaction, outperforming 49 other RCM vendors. Waystar's AltitudeAI™ has notably prevented $15 billion in denials and accelerated appeal package generation by 90%, demonstrating significant operational impact.
AI platform prevents $15B in healthcare claim denials in under a year
Waystar (Nasdaq: WAY) announced it has earned the top industry ranking for AI in revenue cycle management, with its AltitudeAI platform preventing $15 billion in denials in less than a year. A Black Book survey of over 750 healthcare leaders rated Waystar 9.75/10 across 18 KPIs, significantly outperforming competitors. The company also reported a 90% acceleration in appeal package generation and approximately 99% clean claim and first-pass acceptance rates.
Citizens cuts Waystar Holding stock price target on sector multiples By Investing.com
Citizens has reduced its price target for Waystar Holding (NASDAQ:WAY) to $34 from $48, while maintaining a Market Outperform rating. This adjustment is due to broader multiple compression within the software sector and applies a 15x multiple against a revised 2026 EBITDA estimate of $533 million. Despite the price target cut, Citizens remains positive on Waystar, citing the company's AI-related product cycle, strong financials, and robust business model.
These Analysts Cut Their Forecasts On Waystar After Q4 Results
Waystar Holding (NASDAQ: WAY) reported mixed Q4 results, missing analyst consensus on EPS but beating on sales. Following these results and the company's FY2026 guidance, several analysts from firms including Evercore ISI Group, Truist Securities, Barclays, Goldman Sachs, BMO Capital, and Citigroup maintained their ratings but lowered their price targets for the stock.
Waystar Holding Corp. (WAY): Analyst Upgrade Signals Promising Upside Potential
Waystar Holding Corp. (WAY) recently received a "Buy" rating and a $40 price target from Freedom Capital Markets, suggesting significant upside potential from its current trading price of $24.31. Despite recent stock volatility and a 30-day decline, consistent earnings beats and strong analyst consensus with an average price target of $44 indicate promising growth opportunities in the healthcare technology sector. Investors should consider Waystar for long-term growth, while remaining mindful of its past volatility.
Waystar (WAY) climbs 8.5% on swing to profits, double-digit outlook
Waystar (WAY) stock rose by 8.5% following its latest earnings report, which showed a swing to profitability and a double-digit outlook for future growth. Investors reacted positively to the company's financial performance.
Mizuho Lowers Waystar Holding Corp. (WAY) Price Target to $42 Amid Competitive Healthcare Tech Risks
Mizuho has lowered its price target for Waystar Holding Corp. (WAY) to $42 from $50, citing competitive risks in the healthcare technology sector, while maintaining an Outperform rating. Conversely, Leerink initiated coverage with an Outperform rating and a $43 price target, highlighting Waystar's market reach, improved end-to-end products, and strengthened AI capabilities through the Iodine acquisition. Additionally, Waystar announced the resignation of its Chief Business Officer, Eric Sinclair III, effective March 2, 2026, and showcased its enhanced AltitudeAI system, which has prevented $15.5 billion in claim denials.
Mizuho Lowers Waystar Holding Corp. (WAY) Price Target to $42 Amid Competitive Healthcare Tech Risks
Mizuho has adjusted its price target for Waystar Holding Corp. (WAY) to $42 from $50, while maintaining an Outperform rating, due to reassessed competitive risks in the healthcare technology sector. Despite this, Leerink initiated coverage with an Outperform rating and a $43 price target, highlighting Waystar's broad market reach, improved end-to-end products, and enhanced AI capabilities through its acquisition of Iodine. The company continues to innovate, demonstrated by its updated AltitudeAI system preventing $15.5 billion in claim denials, and its Chief Business Officer Eric Sinclair III will resign in March 2026.
Waystar (WAY) Climbs 8.5% on Swing to Profits, Double-Digit Outlook
Waystar Holding Corp. (NASDAQ:WAY) saw its share prices jump by 8.48% after reporting a swing to profitability in the past year, with a net income of $112 million, reversing a $19 million net loss in 2024. The company also provided a strong outlook for 2026, targeting a 20.6% to 27% increase in non-GAAP net income and 16% to 17.7% revenue growth. CEO Matt Hawkins highlighted Waystar's leadership in healthcare's AI transformation and its robust pipeline.
Waystar outlines 17% revenue growth target for 2026 while advancing AI-driven automation and integration
Waystar has set an ambitious target of 17% revenue growth for 2026. The company plans to achieve this by focusing on AI-driven automation and integration strategies within its operations. This move signals Waystar's commitment to leveraging advanced technology to enhance efficiency and expand its market presence.
Beyond The Numbers: 6 Analysts Discuss Waystar Holding Stock
Six analysts have recently provided ratings for Waystar Holding (NASDAQ: WAY), with an average 12-month price target of $40.5, reflecting a 16.2% decrease. The company demonstrates strong financial health with high market capitalization, 11.89% revenue growth, impressive net margin of 11.41%, and robust ROE and ROA, alongside a conservative debt-to-equity ratio. Analysts' collective sentiment spans from bullish to indifferent, with recent adjustments indicating a nuanced view of the company's future performance.
Waystar climbs more than 3% on solid revenue growth and upbeat 2026 outlook
The article reports that Waystar's stock rose over 3% due to strong revenue growth. The positive market reaction is also attributed to an optimistic financial outlook provided for the year 2026. This indicates investor confidence in the company's future performance.
Waystar (WAY) Q4 2025 Earnings Call Transcript
Waystar (WAY) reported strong Q4 and full-year 2025 results, with revenue exceeding $1 billion and adjusted EBITDA at 42%. The acquisition of Iodine Software significantly contributed to growth and market expansion, with integration ahead of schedule and cost synergies expected to be realized sooner. The company emphasizes its leadership in AI-powered revenue cycle automation, with AI embedded in nearly 40% of revenue-generating workflows and driving a substantial portion of new bookings, positioning Waystar for continued "low double-digit" organic growth and sustained high EBITDA margins in 2026.
Earnings call transcript: Waystar Q4 2025 sees 24% revenue growth, stock surges
Waystar Holding Corp. reported robust financial results for Q4 2025, with revenue climbing 24% year-over-year to $304 million and EPS reaching $0.36, surpassing analyst expectations. The company attributes this strong performance to its innovative AI-driven solutions and strategic acquisitions like Iodine Software, which have bolstered its position in healthcare revenue cycle management. Waystar provided optimistic guidance for 2026, projecting revenue between $1.274 billion and $1.294 billion, and plans to launch several new AI agents to continue driving growth and automation.
Waystar (WAY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Waystar (WAY) reported its Q4 earnings for the period ending December 2025, with revenues of $303.54 million, surpassing the Zacks Consensus Estimate by 3.03%. However, the company's EPS of $0.36 missed the consensus estimate of $0.39 by 8.37%. Key metrics such as volume-based revenue, subscription revenue, and implementation services revenue all showed year-over-year increases and largely met or exceeded analyst expectations.
Waystar Holding Corp. SEC 10-K Report
Waystar Holding Corp. has released its annual Form 10-K report, detailing its financial performance, business operations, and strategic initiatives as a leading provider of AI-powered software solutions for healthcare payments. The company highlighted its robust client base, innovative platform capabilities, and growth strategies, including mergers and acquisitions, while also addressing significant challenges such as market competition, regulatory changes, and cybersecurity risks. Waystar aims to leverage AI and cloud-based solutions to capitalize on the evolving healthcare payments landscape.
Waystar: Q4 Earnings Snapshot
Waystar (WAY) reported fourth-quarter earnings of $20 million, or 10 cents per share, which missed Wall Street expectations of 39 cents per share. Despite the earnings miss, the health care payments software maker surpassed revenue forecasts, posting $303.5 million against an anticipated $294.6 million. For the full year, Waystar reported profits of $112.1 million on $1.1 billion in revenue, and provided future earnings guidance of $1.59 to $1.68 per share with revenue between $1.27 billion and $1.29 billion.
AI that helped healthcare providers avoid $15.5B in denials just won
Waystar (Nasdaq: WAY) received the Inc. Best in Business award in the Best AI Implementation category for its AltitudeAI suite, which has helped healthcare providers prevent $15.5 billion in denials. The company's AI technology, embedded in revenue-cycle workflows, has also achieved 95% time savings in denial prevention and increased overturn rates. This recognition highlights Waystar's leadership in AI and its mission to simplify healthcare payments.
Public Sector Pension Investment Board Takes Position in Waystar Holding Corp. $WAY
Public Sector Pension Investment Board recently acquired 448,416 shares of Waystar Holding Corp. (NASDAQ:WAY), valued at approximately $17.0 million, establishing a new position and owning 0.23% of the company. Despite significant insider selling over the past 90 days, analysts maintain a "Buy" consensus rating with an average price target of $45.50, indicating potential upside from its current trading price. Waystar, a provider of cloud-based revenue cycle management for healthcare, also saw other institutional investors increase their stakes.
Some Confidence Is Lacking In Waystar Holding Corp. (NASDAQ:WAY) As Shares Slide 27%
Waystar Holding Corp. (NASDAQ:WAY) shares have fallen 27% in the last month, contributing to a 52% decline over the past year. Despite a high price-to-sales (P/S) ratio of 4x compared to the industry average of 2.1x, the company's revenue growth of 15% last year and a forecast of 14% annual growth for the next three years is similar to the broader Healthcare Services industry. This suggests that Waystar's elevated P/S may not be sustainable if its revenue growth doesn't significantly outperform its peers.
Waystar Holding Corp stock hits 52-week low at 23.08 USD
Waystar Holding Corp's stock has reached a 52-week low of $23.08, representing a 46.24% decline over the past year. This downturn comes amidst recent news of a chief business officer resignation and the introduction of agentic intelligence to its healthcare payment platform. Despite the stock performance, analysts from Leerink Partners, BofA Securities, and Wells Fargo maintain positive outlooks with Buy/Outperform/Overweight ratings and price targets significantly above the current low.
Waystar Holding (WAY) Reports Next Week: Wall Street Expects Earnings Growth
Waystar Holding (WAY) is scheduled to report its quarterly earnings next week, with Wall Street anticipating a year-over-year increase in earnings and revenue for the quarter ended December 2025. The company's Zacks Earnings ESP of +1.82% combined with a Zacks Rank #3 suggests a high probability of beating the consensus EPS estimate. Investors are advised to consider other factors beyond just earnings beats, although the predicted positive surprise makes Waystar a compelling candidate.
Waystar Holding (WAY)'s Broad Market Reach Retains Analyst Confidence Despite Weak Share Price Performance
Waystar Holding (WAY) maintains bullish analyst sentiment, with a consensus price target of $46.00 implying a significant upside despite a 30.68% stock decline over the past year. Leerink initiated coverage with an 'Outperform' rating, citing the company's broad market reach, expanding AI capabilities, and strengthened end-to-end platform for healthcare organizations as growth drivers. However, Waystar recently reached a 52-week low, indicating a gap between its market valuation and potential.
Waystar Holding (WAY) Reports Next Week: Wall Street Expects Earnings Growth
Waystar Holding (WAY) is projected to announce a year-over-year increase in earnings and revenues for the quarter ended December 2025, with expectations of $0.39 EPS and $294.61 million in revenue. The company currently has a positive Earnings ESP of +1.82% and a Zacks Rank #3, suggesting a strong likelihood of beating the consensus EPS estimate. Investors are advised to also consider other factors beyond earnings reports when making investment decisions.
Waystar Holding (WAY)’s Broad Market Reach Retains Analyst Confidence Despite Weak Share Price Performance
Despite a 30.68% decline in share price over the past year, Waystar Holding Corp. (NASDAQ: WAY) maintains strong analyst confidence, with a consensus price target of $46.00 implying a 91.70% upside. Leerink recently initiated coverage with an 'Outperform' rating, citing the company's broad market reach, expanding AI capabilities, and strengthened end-to-end platform for healthcare organizations. While investor sentiment is cautiously optimistic, the article suggests that other AI stocks might offer greater returns and lower risk.
Waystar Holding (WAY) Reports Next Week: Wall Street Expects Earnings Growth
Waystar Holding (WAY) is projected to report a year-over-year increase in earnings and revenues for the quarter ended December 2025, with an expected earnings per share of $0.39 and revenues of $294.61 million. Analysts have recently become more bullish on Waystar's earnings prospects, indicated by a positive Earnings ESP of +1.82% and a Zacks Rank #3, suggesting a strong likelihood of an earnings beat. The company has a history of beating consensus EPS estimates in three of the last four quarters.
Waystar Holding Corp.'s (NASDAQ:WAY) 30% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio
Waystar Holding Corp.'s stock has dropped 30% in the last month and 41% over the past year, yet its Price-to-Sales (P/S) ratio of 4.5x remains high compared to the industry average of 2.2x. Despite recent revenue growth aligning with the industry, analysts forecast similar future revenue growth, suggesting that the current elevated P/S ratio might not be sustainable and could lead to shareholder disappointment if it normalizes. The article questions whether investors are overly bullish given the company's growth outlook.
14 Oversold Value Stocks to Invest in Right Now
The article identifies Waystar Holding Corp. (NASDAQ: WAY) as one of 14 oversold value stocks. Despite a significant share price decline, analysts maintain a bullish outlook, projecting substantial upside potential. The company's expanding AI capabilities and end-to-end platform for healthcare organizations are highlighted as key growth drivers.
Will Waystar (WAY) Beat Estimates Again in Its Next Earnings Report?
Waystar Holding (WAY) is predicted to beat its upcoming earnings estimates, largely due to its strong history of surpassing expectations and a positive Zacks Earnings ESP. The healthcare payments software maker has an average surprise of 8.96% over its last two quarters. Combined with a Zacks Rank #3 (Hold) and an Earnings ESP of +1.82%, analysts anticipate another positive surprise.
Renaissance Group LLC Makes New $8.38 Million Investment in Waystar Holding Corp. $WAY
Renaissance Group LLC recently invested $8.38 million into Waystar Holding Corp. by acquiring 220,847 shares in the third quarter. Despite significant insider selling totaling over $2.5 million, analysts maintain a positive outlook, with a consensus "Buy" rating and a target price of $45.87 against the current trading price of around $24.30. Waystar, a cloud-based revenue cycle management provider for healthcare, shows strong market capitalization and analyst confidence despite recent insider transactions.
Waystar Holding chief business officer to resign in March
Waystar Holding Corp. announced that its chief business officer, Eric (Ric) Sinclair III, will resign on March 2, 2026, to take a position at another company. His departure is not due to any disagreement with Waystar's operations or board. Sinclair will receive his 2025 annual bonus but no additional severance.
Will Waystar (WAY) Beat Estimates Again in Its Next Earnings Report?
Waystar Holding (WAY) is showing strong potential to beat its upcoming earnings estimates, consistent with its past performance. The company, part of the Zacks Internet - Software industry, has a positive Earnings ESP of +1.82% and a Zacks Rank #3 (Hold). This combination historically leads to earnings beats nearly 70% of the time, making Waystar a strong candidate for another positive surprise when it reports on February 17, 2026.
Waystar Holding Corp. Announces Resignation of Eric Sinclair III as Chief Business Officer, Effective March 2, 2026
Waystar Holding Corp. announced the resignation of Eric Sinclair III, its Chief Business Officer, effective March 2, 2026. Sinclair notified the company of his intention to leave on February 2, 2026, to take a position at another company. His resignation is not due to any disagreement with Waystar's operations, policies, or Board of Directors.
Will Waystar (WAY) Beat Estimates Again in Its Next Earnings Report?
Waystar Holding (WAY) is showing strong potential to beat its upcoming earnings estimates, building on a consistent track record of outperforming expectations. With a positive Zacks Earnings ESP of +1.82% and a Zacks Rank #3 (Hold), the company, which belongs to the Internet - Software industry, has a high probability of delivering another positive surprise. Its next earnings report is anticipated on February 17, 2026.
Hospitals lose billions to denials; Waystar's AI tops KLAS
Waystar (Nasdaq: WAY) has once again been recognized as Best in KLAS for Patient Access, marking over a decade of consecutive honors. The company's AI-powered platform, Waystar AltitudeAI, is highlighted for its effectiveness in addressing significant financial challenges in healthcare, such as reducing eligibility denials by up to 55% and achieving up to 90% auto-approval rates on prior authorizations. This recognition underscores Waystar's role in helping healthcare providers optimize financial performance and improve patient access to care.
Waystar to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026
Waystar Holding Corp. (Nasdaq: WAY) announced it will report its financial results for the fourth quarter and fiscal year ending December 31, 2025, before market open on Tuesday, February 17, 2026. The company will host a conference call at 8:30 a.m. Eastern Time on the same day to discuss these results. A live audio webcast will be available on Waystar's investor relations website.
Waystar to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026
Waystar Holding Corp. (Nasdaq: WAY) will announce its financial results for the fourth quarter and fiscal year ended December 31, 2025, before market open on Tuesday, February 17, 2026. The healthcare payment software provider will hold a conference call at 8:30 a.m. Eastern Time on the same day to discuss these results, with a live audio webcast available on its investor relations website.
Waystar Holding Corp. $WAY Shares Purchased by Thrivent Financial for Lutherans
Thrivent Financial for Lutherans significantly increased its stake in Waystar Holding Corp. (NASDAQ:WAY) by 2,923.3% in Q3, acquiring an additional 853,239 shares to hold 882,427 shares valued at $33.46 million. Other major institutional investors like William Blair Investment Management LLC and Alliancebernstein L.P. also substantially boosted their holdings, indicating broad institutional interest. Despite a consensus "Buy" rating from analysts with an average price target of $46.40, company insiders have sold approximately 80,273 shares totaling over $2.5 million in the last 90 days.
Waystar to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on February 17, 2026
Waystar Holding Corp. (Nasdaq: WAY) announced it will report its financial results for the fourth quarter and fiscal year ended December 31, 2025, before the market opens on Tuesday, February 17, 2026. The company will host a conference call at 8:30 a.m. Eastern Time on the same day to discuss its results, with a live audio webcast available on its investor relations website. Waystar, a provider of healthcare payment software, aims to simplify healthcare payments for providers and serves over 30,000 clients.
Leerink Partners initiates Waystar stock with Outperform rating, $43 price target
Leerink Partners has initiated coverage on Waystar Holding (NASDAQ:WAY) with an Outperform rating and a $43 price target, citing the company's strong market reach, AI capabilities enhanced by the Iodine acquisition, and diverse customer base. The firm believes Waystar is well-positioned for growth despite upcoming headwinds, with its stock currently undervalued and in oversold territory. This positive outlook is echoed by other analysts, including BofA Securities, Wells Fargo, RBC Capital, and UBS, all of whom have recent positive ratings and price targets for Waystar.
Leerink Partners Initiates Coverage on Waystar With Outperform Rating, $43 Price Target
Leerink Partners has initiated coverage on Waystar Holding Corp. with an Outperform rating and a price target of $43.00. The report notes Waystar's recent financial performance, including increased adjusted earnings and revenue for Q3 2025, and provides an outlook for the full fiscal year 2025. This follows several other analyst initiations and insider transaction reports for the company.
Waystar Holding Corp. (NASDAQ:WAY) Short Interest Down 17.4% in January
Waystar Holding Corp. (NASDAQ:WAY) experienced a significant decrease in short interest, falling 17.4% to 7,514,927 shares as of January 15th, representing approximately 4.1% of shares sold short. Despite company insiders being net sellers, Wall Street analysts maintain a "Buy" rating with a consensus target price of $46.64, suggesting substantial upside from the stock's recent open of $26.56. The company, a cloud-based revenue cycle management provider for healthcare, has a market cap of $5.08 billion and a P/E ratio of 42.84.
Federated Hermes Inc. Acquires 72,274 Shares of Waystar Holding Corp. $WAY
Federated Hermes Inc. increased its stake in Waystar Holding Corp. by 9.0% in the third quarter of 2025, purchasing 72,274 additional shares to hold a total of 873,992 shares valued at approximately $33.14 million. Despite this, Waystar insiders have been net sellers, disposing of 80,273 shares worth about $2.57 million in the last 90 days. Analysts maintain a consensus "Buy" rating for Waystar, with an average price target of $46.64, significantly higher than its recent trading price around $26.56.
Lisanti Capital Growth LLC Makes New $4 Million Investment in Waystar Holding Corp. $WAY
Lisanti Capital Growth LLC has made a new $4 million investment in Waystar Holding Corp. (NASDAQ: WAY), purchasing 105,540 shares in Q3, now owning 0.06% of the company. Despite recent insider selling by the CTO and CMO totaling approximately $2.57 million, company insiders still hold about 4.10% of the stock. Wall Street analysts maintain a consensus "Buy" rating with an average price target of $46.64 for Waystar.
Waystar Holding Taps EDB Postgres AI To Power Next‑Phase Growth
Waystar Holding Corp. has adopted EDB Postgres AI to enhance its mission-critical healthcare payments platform, aiming for improved reliability and operational performance within the highly regulated healthcare environment. This strategic move is expected to support more complex AI-powered workflows and align with Waystar's existing focus on AI-driven automation, which could influence its future service offerings and competitive positioning against industry peers. Investors should monitor this partnership as it signals how Waystar is preparing its core platform for scalability and product development in the evolving healthcare payments sector.
Waystar Adopts EDB Postgres AI As Shares Trade Below Valuation Estimates
Waystar Holding Corp. (NasdaqGS:WAY) is integrating EDB Postgres AI to enhance its healthcare payments data infrastructure, focusing on operational efficiency and data sovereignty amidst challenging stock performance. Despite a recent decline in share price and negative momentum, the company believes this technological adoption will improve its ability to handle sensitive, regulated healthcare payment data at scale. Analysts and Simply Wall St currently
Waystar Holding Corp stock hits 52-week low at 28.09 USD
Waystar Holding Corp's stock has fallen to a new 52-week low of $28.09, representing a 30.68% decrease over the past year. Despite this downturn, InvestingPro data suggests the company is undervalued with a PEG ratio of 0.19 and maintains "GREAT" financial health. Analysts remain optimistic with a consensus "strong buy" recommendation and a high price target of $54.
Waystar Holding Corp. $WAY Stake Increased by Kornitzer Capital Management Inc. KS
Kornitzer Capital Management Inc. KS significantly increased its stake in Waystar Holding Corp. ($WAY) by 65.9% in Q3 2025, acquiring 68,490 shares to own 172,380 shares valued at approximately $6.54 million. This move is part of a broader trend of institutional buying, with other major firms like AllianceBernstein, Norges Bank, William Blair, Voya, and Man Group also boosting their positions in the healthcare revenue cycle management company. Despite strong institutional interest and an average "Buy" rating from analysts with a target price of $46.64, insiders have been net sellers, offloading 80,273 shares in the past 90 days.
Analysts Offer Insights on Technology Companies: Waystar Holding Corp. (WAY), Avnet (AVT) and Apple (AAPL)
Analysts from RBC Capital, Wells Fargo, and J.P. Morgan have provided their insights on several technology companies. Ryan Halsted reiterated a Buy rating for Waystar Holding Corp. with a $44.00 price target, while Joseph Quatrochi maintained a Sell rating for Avnet with a $43.00 price target. Samik Chatterjee upheld a Buy rating for Apple, setting a price target of $315.00.
